Ideaya Biosciences (IDYA) is down -6.0%, or -$1.96 to $30.79.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IDYA:
- IDEAYA Biosciences: Operational Trial Delay but High Conviction Buy Ahead of Key Darovasertib Readout
- IDEAYA Biosciences: Expanding Precision Oncology Platform and Refocused MTAP Strategy Support Buy Rating
- Ideaya Biosciences enrolls first patient in IDE892 trial
- Citi opens ‘upside 90-day catalyst watch’ on Ideaya Biosciences
- Ideaya Biosciences enrolls first patient in IDE034 trial